Facebook Pixel Code

Ipca Laboratories Share Price

NSE
BSE

IPCA LABORATORIES

Midcap | BSE

Here's the live share price of Ipca Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹1,646.25 Closed
2.52₹ 40.50
As on May 18, 2026, 04:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Ipca Laboratories Price Performance

Today's LowToday's High
₹1,590.00₹1,657.00
₹1,646.25
52 Weeks' Low52 Weeks' High
₹1,252.95₹1,654.00
₹1,646.25
Open Price
₹1,643.60
Prev. Close
₹1,605.75
Volume
26,674

Ipca Laboratories Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Ipca Laboratories
6.0912.669.7512.5318.2233.588.61
Sun Pharmaceutical Industries
3.1312.5212.098.029.8126.4522.63
Divi's Laboratories
1.638.2710.804.538.5527.6411.02
Torrent Pharmaceuticals
0.325.733.1415.1334.6139.3726.02
Cipla
5.8515.915.22-7.14-4.8715.6610.12
Dr. Reddy's Laboratories
2.798.854.736.818.0313.754.83
Mankind Pharma
3.1718.9720.2711.54-2.5022.6111.95
Lupin
-5.46-3.371.249.578.6941.7013.59
Zydus Lifesciences
5.575.548.926.099.7724.3110.14
Aurobindo Pharma
0.738.1726.5421.1924.7632.678.39
Laurus Labs
7.9517.4931.0429.82120.1361.5122.93
Biocon
11.9821.5712.071.1525.5220.082.01
Glenmark Pharmaceuticals
-1.113.9315.1025.3261.5456.7231.08
Alkem Laboratories
-2.14-1.98-0.42-4.644.5316.9312.85
Abbott India
4.517.745.86-5.87-8.829.6011.42
Anthem Biosciences
1.279.9315.4119.398.782.851.70
GlaxoSmithKline Pharmaceuticals
-3.83-1.22-8.04-4.08-15.4922.809.50
Ajanta Pharma
5.8613.509.0928.2223.3436.3019.69
Gland Pharma
13.3824.3819.3418.9947.0716.86-5.02
J B Chemicals & Pharmaceuticals
-1.687.146.9716.1028.4728.4425.22

Over the last one year, Ipca Laboratories has gained 18.22% compared to peers like Sun Pharmaceutical Industries (9.81%), Divi's Laboratories (8.55%), Torrent Pharmaceuticals (34.61%). From a 5 year perspective, Ipca Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (22.63%) and Divi's Laboratories (11.02%).

Ipca Laboratories Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Ipca Laboratories Stock Technicals

Moving Average

DaySMAEMA
51,548.161,564.65
101,548.871,550.93
201,531.531,536.48
501,520.081,516.37
1001,490.981,490.87
2001,433.61,459.72

Ipca Laboratories Share Holding Pattern

In the latest quarter, Ipca Laboratories remained same as its previous close in promoter holding, while DII stake increased to 37.45%, FII holding rose to 10.63%, and public shareholding moved down to 7.21% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Ipca Laboratories Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
1,80,96,6282.922,770.41
1,23,48,0472.981,890.36
40,05,4251.9613.19
31,00,0001.04474.58
29,90,2782.35457.78
25,10,0001.27384.26
24,97,1230.36382.28
21,01,0471.8321.65
18,17,7031.61278.27
17,25,8131.62264.2

* Excluding Index & Arbitrage Funds

View All Mutual Funds

Ipca Laboratories Corporate Actions

Date Time
Announcement
May 04, 2026, 10:01 PM IST ISTIpca Laboratories - Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial
Apr 08, 2026, 05:28 PM IST ISTIpca Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Feb 18, 2026, 07:08 PM IST ISTIpca Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 16, 2026, 10:57 PM IST ISTIpca Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 13, 2026, 07:11 PM IST ISTIpca Laboratories - Standalone And Consolidated Financial Results For Q3FY26

About Ipca Laboratories

Ipca Laboratories Ltd. is a Public Limited Listed company incorporated on 19/10/1949 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1949PLC007837 and registration number is 007837. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 6677.92 Cr. and Equity Capital is Rs. 25.37 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Premchand Godha
    Executive Chairman
  • Mr. Ajit Kumar Jain
    Managing Director & CFO
  • Mr. Pranay Godha
    Managing Director & CEO
  • Mr. Prashant Godha
    Executive Director
  • Dr.(Ms.) Swati Patankar
    Independent Director
  • Dr. Narendra Mairpady
    Independent Director
  • Mr. Vivek Shiralkar
    Independent Director
  • Mr. Kamal Kishore Seth
    Independent Director

FAQs on Ipca Laboratories Share Price

What is the share price of Ipca Laboratories?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ipca Laboratories is ₹1,646.25 as on May 18, 2026.

What kind of stock is Ipca Laboratories?

The Ipca Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.

What is the Market Cap of Ipca Laboratories?

The market cap of Ipca Laboratories is ₹41,766.06 Cr as on May 18, 2026.

What are today's High and Low prices of Ipca Laboratories?

Today’s highest and lowest price of Ipca Laboratories are ₹1,657.00 and ₹1,590.00.

What are the 52 Week High and 52 Week Low of Ipca Laboratories?

The 52-week high/low is the highest and lowest price at which Ipca Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Ipca Laboratories is ₹1,654.00 and 52-week low of Ipca Laboratories is ₹1,252.95 as on May 18, 2026.

How has the Ipca Laboratories performed historically in terms of returns?

The Ipca Laboratories has shown returns of 2.52% over the past day, 12.66% for the past month, 9.75% over 3 months, 18.22% over 1 year, 33.58% across 3 years, and 8.61% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Ipca Laboratories?

P/E ratio of and PB ratio of Ipca Laboratories are 45.90 and 5.36 on May 18, 2026. While the company gives a dividend yield of 0.24 per annum.

icon
Market Pulse